Your browser doesn't support javascript.
loading
HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics.
Laino, Andressa S; Betts, B C; Veerapathran, A; Dolgalev, I; Sarnaik, A; Quayle, S N; Jones, S S; Weber, J S; Woods, David M.
Afiliação
  • Laino AS; NYU Langone Health, 522 First Avenue, 1306 Smilow Research Building, New York, NY, 10016, USA. Andressa.Laino@nyumc.org.
  • Betts BC; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
  • Veerapathran A; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
  • Dolgalev I; NYU Langone Health, 522 First Avenue, 1306 Smilow Research Building, New York, NY, 10016, USA.
  • Sarnaik A; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
  • Quayle SN; Acetylon Pharmaceuticals, Boston, MA, USA.
  • Jones SS; Regenacy Pharmaceuticals, Boston, MA, USA.
  • Weber JS; NYU Langone Health, 522 First Avenue, 1306 Smilow Research Building, New York, NY, 10016, USA.
  • Woods DM; NYU Langone Health, 522 First Avenue, 1306 Smilow Research Building, New York, NY, 10016, USA.
J Immunother Cancer ; 7(1): 33, 2019 02 06.
Article em En | MEDLINE | ID: mdl-30728070

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Linfócitos T / Inibidores de Histona Desacetilases / Desacetilase 6 de Histona / Ácidos Hidroxâmicos / Melanoma Limite: Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Linfócitos T / Inibidores de Histona Desacetilases / Desacetilase 6 de Histona / Ácidos Hidroxâmicos / Melanoma Limite: Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2019 Tipo de documento: Article